CONNOR GILBERT: Open Payments
NPI 1174221469 · EVANS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,600 in 90 payments from 24 companies in 2025. Trend: 2023 $1,709 · 2024 $557 · 2025 $1,600
Food & beverage: $1,600
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $238 |
| Amgen Inc. | 13 | $175 |
| AstraZeneca Pharmaceuticals LP | 6 | $148 |
| Novartis Pharmaceuticals Corporation | 9 | $136 |
| Dexcom, Inc. | 6 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $82 |
| Corcept Therapeutics | 4 | $73 |
| Phathom Pharmaceuticals, Inc. | 5 | $67 |
| ABBVIE INC. | 3 | $60 |
| Esperion Therapeutics, Inc. | 3 | $49 |
Products named: Ozempic, LEQVIO, Dexcom G6 Transmitter, AIRSUPRA, Kerendia, EVENITY, OTEZLA, Wegovy.
Industry payments across GA — which companies pay providers there.
